Atara Biotherapeutics, Inc. (0HIY)
Market Closed
16 Oct, 03:30 PM
LSE 
$
9. 49
-0.04
-0.4197%
$
- Market Cap
- P/E Ratio
- Div Yield
118 Volume
-2.6 Eps
$ 9.53
Previous Close Want to track 0HIY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Atara Biotherapeutics, Inc. (0HIY) Statistics
Valuation metrics
Market Cap -
Enterprise value 98.8M
Trailing P/E (ttm) -7.78
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 14.88
Price/Book (mrq) -3.73
Enterprise Value/Revenue 15.95
Enterprise Value/EBITDA -7.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 116
Average volume (90 days) 669
Price summary
52-Week low 4.02
52-Week high 19.05
Beta -
50-Day moving average 9.26
200-Day moving average 8.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.04:1
Last split Date 20 Jun 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.69%
Operating margin -2.3%
Operational effectiveness
Return on assets -0.79%
Return on equity 0.45%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.41
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.66
Total debt (mrq) -
Total Debt/Equity (mrq) -0.27
Current ratio (mrq) 1.98%
Book value per share (mrq) -2.46
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
